Funding Rounds
MinervaX

MinervaX Debt Financing (2022, $53M)

MinervaX

Developer of prophylactic vaccine against Group B Streptococcus.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Debt Financing

Raised Amount: $53.26M

Investors